Expansion to the Motion Sickness Susceptibility Questionnaire-Short Form: A Cross-Sectional Study.
Motion sickness
Proprioception
Questionnaire
Virtual reality
Journal
Journal of audiology & otology
ISSN: 2384-1621
Titre abrégé: J Audiol Otol
Pays: Korea (South)
ID NLM: 101657815
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
06
10
2021
accepted:
30
12
2021
pubmed:
24
2
2022
medline:
24
2
2022
entrez:
23
2
2022
Statut:
ppublish
Résumé
The primary objective of this study is to investigate the necessity of questioning virtual reality systems in the motion sickness susceptibility questionnaire (MSSQ)-short form. The secondary objective of this study is to determine the validity and reliability of the Turkish version of the MSSQ-short form, with proven validity and reliability. In the questionnaire form, for which expert opinion was obtained to maintain linguistic equivalence, the virtual reality items were added to the questionnaire. The questionnaire was then administered to 297 individuals. The results were statistically analyzed with and without these virtual reality items for validity and reliability. After the addition of the virtual reality items, the reliability of the questionnaire was found to be quite high (Cronbach's alpha r=0.912). The norm values between the original MSSQ-short form (12.9±9.9) and the Turkish MSSQ-short form (13.8±12.9) were found to be consistent. Motion sickness symptoms can occur not only during movement, but also with indirect stimulus. Our findings suggest that adding virtual reality items to the original form is important in long term practical applications. Our results show that the Turkish version of the original questionnaire is quite reliable. Submission of the MSSQ-short form in Turkish will be useful for documentation and will also encourage further research in this area.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
The primary objective of this study is to investigate the necessity of questioning virtual reality systems in the motion sickness susceptibility questionnaire (MSSQ)-short form. The secondary objective of this study is to determine the validity and reliability of the Turkish version of the MSSQ-short form, with proven validity and reliability.
SUBJECTS AND METHODS
METHODS
In the questionnaire form, for which expert opinion was obtained to maintain linguistic equivalence, the virtual reality items were added to the questionnaire. The questionnaire was then administered to 297 individuals. The results were statistically analyzed with and without these virtual reality items for validity and reliability.
RESULTS
RESULTS
After the addition of the virtual reality items, the reliability of the questionnaire was found to be quite high (Cronbach's alpha r=0.912). The norm values between the original MSSQ-short form (12.9±9.9) and the Turkish MSSQ-short form (13.8±12.9) were found to be consistent.
CONCLUSIONS
CONCLUSIONS
Motion sickness symptoms can occur not only during movement, but also with indirect stimulus. Our findings suggest that adding virtual reality items to the original form is important in long term practical applications. Our results show that the Turkish version of the original questionnaire is quite reliable. Submission of the MSSQ-short form in Turkish will be useful for documentation and will also encourage further research in this area.
Identifiants
pubmed: 35196446
pii: jao.2021.00577
doi: 10.7874/jao.2021.00577
pmc: PMC8996090
doi:
Types de publication
Journal Article
Langues
eng
Pagination
76-82Références
Exp Brain Res. 2014 Aug;232(8):2493-510
pubmed: 24961738
Cases J. 2009 Dec 21;2:9367
pubmed: 20062612
Eur Spine J. 2016 Feb;25(2):438-43
pubmed: 26077100
Aviat Space Environ Med. 2005 Oct;76(10):970-3
pubmed: 16235881
Acta Otolaryngol. 2017 May;137(5):495-502
pubmed: 27918236
Auton Neurosci. 2006 Oct 30;129(1-2):67-76
pubmed: 16931173
Exp Brain Res. 2014 Aug;232(8):2483-92
pubmed: 24838552
J Vestib Res. 2013;23(4-5):203-9
pubmed: 24284600
PLoS One. 2016 Apr 29;11(4):e0154528
pubmed: 27128970
J Otolaryngol. 2002 Dec;31(6):381-5
pubmed: 12593552
Front Neurol. 2017 Apr 04;8:114
pubmed: 28421029
Appl Ergon. 2018 May;69:66-73
pubmed: 29477332